Monthly News Roundup - January 2016
Merck’s Once-Daily Zepatier for Hepatitis C Wins Approval
Hepatitis C virus (HCV) affects over 3 millions Americans, and may lead to liver impairment, cirrhosis or even liver failure. In January, the U.S. Food and Drug Administration (FDA)...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cirrhosis | Food and Drug Administration (FDA) | Hepatitis | Hepatitis C | Liver | Pharmaceuticals | Urology & Nephrology